Cargando…

A model of type 2 diabetes in the guinea pig using sequential diet-induced glucose intolerance and streptozotocin treatment

Type 2 diabetes is a leading cause of morbidity and mortality among noncommunicable diseases, and additional animal models that more closely replicate the pathogenesis of human type 2 diabetes are needed. The goal of this study was to develop a model of type 2 diabetes in guinea pigs, in which diet-...

Descripción completa

Detalles Bibliográficos
Autores principales: Podell, Brendan K., Ackart, David F., Richardson, Michael A., DiLisio, James E., Pulford, Bruce, Basaraba, Randall J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Company of Biologists Ltd 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5312002/
https://www.ncbi.nlm.nih.gov/pubmed/28093504
http://dx.doi.org/10.1242/dmm.025593
_version_ 1782508129300250624
author Podell, Brendan K.
Ackart, David F.
Richardson, Michael A.
DiLisio, James E.
Pulford, Bruce
Basaraba, Randall J.
author_facet Podell, Brendan K.
Ackart, David F.
Richardson, Michael A.
DiLisio, James E.
Pulford, Bruce
Basaraba, Randall J.
author_sort Podell, Brendan K.
collection PubMed
description Type 2 diabetes is a leading cause of morbidity and mortality among noncommunicable diseases, and additional animal models that more closely replicate the pathogenesis of human type 2 diabetes are needed. The goal of this study was to develop a model of type 2 diabetes in guinea pigs, in which diet-induced glucose intolerance precedes β-cell cytotoxicity, two processes that are crucial to the development of human type 2 diabetes. Guinea pigs developed impaired glucose tolerance after 8 weeks of feeding on a high-fat, high-carbohydrate diet, as determined by oral glucose challenge. Diet-induced glucose intolerance was accompanied by β-cell hyperplasia, compensatory hyperinsulinemia, and dyslipidemia with hepatocellular steatosis. Streptozotocin (STZ) treatment alone was ineffective at inducing diabetic hyperglycemia in guinea pigs, which failed to develop sustained glucose intolerance or fasting hyperglycemia and returned to euglycemia within 21 days after treatment. However, when high-fat, high-carbohydrate diet-fed guinea pigs were treated with STZ, glucose intolerance and fasting hyperglycemia persisted beyond 21 days post-STZ treatment. Guinea pigs with diet-induced glucose intolerance subsequently treated with STZ demonstrated an insulin-secretory capacity consistent with insulin-independent diabetes. This insulin-independent state was confirmed by response to oral antihyperglycemic drugs, metformin and glipizide, which resolved glucose intolerance and extended survival compared with guinea pigs with uncontrolled diabetes. In this study, we have developed a model of sequential glucose intolerance and β-cell loss, through high-fat, high-carbohydrate diet and extensive optimization of STZ treatment in the guinea pig, which closely resembles human type 2 diabetes. This model will prove useful in the study of insulin-independent diabetes pathogenesis with or without comorbidities, where the guinea pig serves as a relevant model species.
format Online
Article
Text
id pubmed-5312002
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher The Company of Biologists Ltd
record_format MEDLINE/PubMed
spelling pubmed-53120022017-03-06 A model of type 2 diabetes in the guinea pig using sequential diet-induced glucose intolerance and streptozotocin treatment Podell, Brendan K. Ackart, David F. Richardson, Michael A. DiLisio, James E. Pulford, Bruce Basaraba, Randall J. Dis Model Mech Research Article Type 2 diabetes is a leading cause of morbidity and mortality among noncommunicable diseases, and additional animal models that more closely replicate the pathogenesis of human type 2 diabetes are needed. The goal of this study was to develop a model of type 2 diabetes in guinea pigs, in which diet-induced glucose intolerance precedes β-cell cytotoxicity, two processes that are crucial to the development of human type 2 diabetes. Guinea pigs developed impaired glucose tolerance after 8 weeks of feeding on a high-fat, high-carbohydrate diet, as determined by oral glucose challenge. Diet-induced glucose intolerance was accompanied by β-cell hyperplasia, compensatory hyperinsulinemia, and dyslipidemia with hepatocellular steatosis. Streptozotocin (STZ) treatment alone was ineffective at inducing diabetic hyperglycemia in guinea pigs, which failed to develop sustained glucose intolerance or fasting hyperglycemia and returned to euglycemia within 21 days after treatment. However, when high-fat, high-carbohydrate diet-fed guinea pigs were treated with STZ, glucose intolerance and fasting hyperglycemia persisted beyond 21 days post-STZ treatment. Guinea pigs with diet-induced glucose intolerance subsequently treated with STZ demonstrated an insulin-secretory capacity consistent with insulin-independent diabetes. This insulin-independent state was confirmed by response to oral antihyperglycemic drugs, metformin and glipizide, which resolved glucose intolerance and extended survival compared with guinea pigs with uncontrolled diabetes. In this study, we have developed a model of sequential glucose intolerance and β-cell loss, through high-fat, high-carbohydrate diet and extensive optimization of STZ treatment in the guinea pig, which closely resembles human type 2 diabetes. This model will prove useful in the study of insulin-independent diabetes pathogenesis with or without comorbidities, where the guinea pig serves as a relevant model species. The Company of Biologists Ltd 2017-02-01 /pmc/articles/PMC5312002/ /pubmed/28093504 http://dx.doi.org/10.1242/dmm.025593 Text en © 2017. Published by The Company of Biologists Ltd http://creativecommons.org/licenses/by/3.0This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.
spellingShingle Research Article
Podell, Brendan K.
Ackart, David F.
Richardson, Michael A.
DiLisio, James E.
Pulford, Bruce
Basaraba, Randall J.
A model of type 2 diabetes in the guinea pig using sequential diet-induced glucose intolerance and streptozotocin treatment
title A model of type 2 diabetes in the guinea pig using sequential diet-induced glucose intolerance and streptozotocin treatment
title_full A model of type 2 diabetes in the guinea pig using sequential diet-induced glucose intolerance and streptozotocin treatment
title_fullStr A model of type 2 diabetes in the guinea pig using sequential diet-induced glucose intolerance and streptozotocin treatment
title_full_unstemmed A model of type 2 diabetes in the guinea pig using sequential diet-induced glucose intolerance and streptozotocin treatment
title_short A model of type 2 diabetes in the guinea pig using sequential diet-induced glucose intolerance and streptozotocin treatment
title_sort model of type 2 diabetes in the guinea pig using sequential diet-induced glucose intolerance and streptozotocin treatment
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5312002/
https://www.ncbi.nlm.nih.gov/pubmed/28093504
http://dx.doi.org/10.1242/dmm.025593
work_keys_str_mv AT podellbrendank amodeloftype2diabetesintheguineapigusingsequentialdietinducedglucoseintoleranceandstreptozotocintreatment
AT ackartdavidf amodeloftype2diabetesintheguineapigusingsequentialdietinducedglucoseintoleranceandstreptozotocintreatment
AT richardsonmichaela amodeloftype2diabetesintheguineapigusingsequentialdietinducedglucoseintoleranceandstreptozotocintreatment
AT dilisiojamese amodeloftype2diabetesintheguineapigusingsequentialdietinducedglucoseintoleranceandstreptozotocintreatment
AT pulfordbruce amodeloftype2diabetesintheguineapigusingsequentialdietinducedglucoseintoleranceandstreptozotocintreatment
AT basarabarandallj amodeloftype2diabetesintheguineapigusingsequentialdietinducedglucoseintoleranceandstreptozotocintreatment
AT podellbrendank modeloftype2diabetesintheguineapigusingsequentialdietinducedglucoseintoleranceandstreptozotocintreatment
AT ackartdavidf modeloftype2diabetesintheguineapigusingsequentialdietinducedglucoseintoleranceandstreptozotocintreatment
AT richardsonmichaela modeloftype2diabetesintheguineapigusingsequentialdietinducedglucoseintoleranceandstreptozotocintreatment
AT dilisiojamese modeloftype2diabetesintheguineapigusingsequentialdietinducedglucoseintoleranceandstreptozotocintreatment
AT pulfordbruce modeloftype2diabetesintheguineapigusingsequentialdietinducedglucoseintoleranceandstreptozotocintreatment
AT basarabarandallj modeloftype2diabetesintheguineapigusingsequentialdietinducedglucoseintoleranceandstreptozotocintreatment